Systematic ReviewPublished 12 October 2026Chinese medicine combined with EGFR-TKIs in EGFR-mutated advanced NSCLC: a meta-analysis of efficacy and safetyXiaohong Li · Die Qian · Shuai Liu · Mingmin Na · Bihong Dai · Chunping WanFrontiers in Oncologydoi 10.3389/fonc.2026.1942222
Original ResearchPublished 12 October 2026EGFR-TKI-associated colitis in non-small cell lung cancer: a retrospective characterization of clinical, radiographic, endoscopic, and histopathologic featuresShujun Wang · Chen Tan · Pufang Shi · Ya Li · Hefeng Zhan · Jiajing LiFrontiers in Pharmacologydoi 10.3389/fphar.2026.1935622
Original ResearchPublished 8 July 2026Prognostic value of baseline 18 F-FDG PET/CT metabolic parameters in EGFR-mutant lung adenocarcinoma patients treated with EGFR-TKIsLei Wang · Zhenpeng Wang · Wei WuFrontiers in Nuclear Medicinedoi 10.3389/fnume.2026.1864776
